On March 24, 2025, Alaa Farouk, the Egyptian Minister of Agriculture and Land Reclamation, convened a significant meeting with Dr. Magdy El-Sayed, the Chairman of the Board of Directors of Mivac Egypt. The focus of their discussion revolved around increasing the production capacity of veterinary vaccines and enhancing the technology needed for their manufacture in Egypt, ultimately targeting export opportunities.
The meeting took place with the participation of key figures, including Dr. Saad Moussa, supervisor of foreign agricultural relations, Dr. Mohamed Saad, director of the Institute of Sera and Vaccines, and Dr. Ahmed Al-Qadi, the executive director of Mivac. Minister Farouk reiterated the directives of President Abdel Fattah El-Sisi, emphasizing the critical need to localize industrial technologies, which are currently imported, to foster economic growth. This initiative is aimed at creating added value for national products, boosting foreign currency inflows, and reducing import bills while generating a range of job opportunities.
"The importance of compiling a comprehensive study of all veterinary vaccines utilized in Egypt cannot be understated," Farouk stressed. He called for expanding the local manufacturing capabilities of feasible vaccines and highlighted the government's support for the private sector. The aim is to eliminate obstacles, thus ensuring a conducive environment for businesses to thrive.
Dr. Magdy El-Sayed showcased the remarkable advancements achieved by Mivac. This company, established with Egyptian-American-Arab investments exceeding 5 billion Egyptian pounds, has a track record of producing diverse vaccines. Founded in 2008 and opened in 2011, Mivac has successfully developed and manufactured more than 77 different vaccines designed to protect livestock from severe epidemic threats.
The company has multiple production lines — over four — and boasts a production capacity that surpasses 4 billion doses per year. Furthermore, Dr. El-Sayed revealed ambitious plans for the company to undertake additional production lines aimed at hitting a target of 12 billion doses by 2025 and 2026. This expansion is largely motivated by the need to satisfy export demands, supported by Mivac's record of registering and selling vaccines in over 40 countries across Africa, the Middle East, Asia, Eastern Europe, and Latin America.
As the leader in veterinary vaccine exports in Egypt, Mivac is not only crucial to ensuring the health of the livestock and poultry sectors but also plays a significant role in enhancing job availability, projecting to provide thousands of direct and indirect employment opportunities. Dr. El-Sayed also indicated that the company is preparing to inaugurate a new factory in the Salhia area soon in collaboration with local and international partners, reaffirming its goal to expand further within the veterinary vaccine production sector.
In concluding the meeting, Minister Farouk directed that a cooperation protocol be established between the Ministry of Agriculture, represented by the Institute of Sera and Veterinary Vaccines, and Mivac. He emphasized the necessity of increasing the company's export quota to African countries as part of Egypt's strategy to reinforce collaboration with African partners in the realm of veterinary vaccine production.
This collaborative approach between public entities and the private sector reflects Egypt's commitment to self-sufficiency and economic resilience, particularly in the critical area of veterinary care that impacts agricultural productivity and food security nationally.
